Manufacturing and marketing of branded and generic pharmaceutical formulations in India.
Annual revenue $35,532 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Roxas Pharmaceuticals

Roxas Pharmaceuticals is a company. Roxas Pharmaceuticals offers products and services including Calcirox-M and Floxi-Kid.

Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Consumer → Food & Beverage Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $35.53 K (USD)
    12.59
    as on Mar 31, 2022
  • Net Profit
    $856.41 (USD)
    1184.42
    as on Mar 31, 2022
  • EBITDA
    $11.05 K (USD)
    9.57
    as on Mar 31, 2022
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Roxas Pharmaceuticals

Roxas Pharmaceuticals offers a comprehensive portfolio of products and services, including Calcirox-M and Floxi-Kid.

Product name locked
Category locked
Primary

Calcirox-M is manufactured as a branded pharmaceutical product for therapeutic use

Product name locked
Category locked
Locked

Floxi-Kid is marketed as a generic pharmaceutical formulation in various therapeutic areas

Funding Insights of Roxas Pharmaceuticals

Premium access

Detailed funding history for Roxas Pharmaceuticals

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Roxas Pharmaceuticals

Investments
Premium access

Investment portfolio details for Roxas Pharmaceuticals

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Roxas Pharmaceuticals

Premium access

Detailed financials for Roxas Pharmaceuticals

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Roxas Pharmaceuticals Comparisons

Roxas Pharmaceuticals Primary company
Description
Manufacturing and marketing of branded and generic pharmaceu...
Location
-
Founded Year
-
Annual Revenue
$35.53 K (USD)
Net Profit
$856.41 (USD)
EBITDA
$11.05 K (USD)
Employees
Not available
Premium access

Peer comparison for Roxas Pharmaceuticals

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Roxas Pharmaceuticals

Premium access

Detailed competitors of Roxas Pharmaceuticals

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Roxas Pharmaceuticals

Premium access

Complete news archive for Roxas Pharmaceuticals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Roxas Pharmaceuticals

Annual revenue of Roxas Pharmaceuticals is $35.53K as on Mar 31, 2022.

Roxas Pharmaceuticals is recognized as a pharmaceutical entity that has been operational since 2014, with its base in Delhi, India. It is involved in the production and distribution of branded and generic formulations across multiple therapeutic segments, supported by a network of over 100 marketing representatives. Quality management is maintained through employee training programs and compliance with Indian Pharmacopeia guidelines for raw materials, processes, and finished products. The companys commitment to high standards is evident in its innovative prescription drug offerings, ensuring reliability in the healthcare sector.

Roxas Pharmaceuticals offers Calcirox-M and Floxi-Kid.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available